Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yasmeen Ghani"'
Publikováno v:
PLoS Pathogens, Vol 9, Iss 1, p e1003145 (2013)
Reverse genetics in the mosquito Anopheles gambiae by RNAi mediated gene silencing has led in recent years to an advanced understanding of the mosquito immune response against infections with bacteria and malaria parasites. We developed RNAi screens
Externí odkaz:
https://doaj.org/article/23c55539969d4de6b3676a9dd1b61932
Publikováno v:
Journal of Immunotherapy. 30:140-149
In the present article we describe the immunogenicity in the mouse of 2 epitopes from the tumor-associated antigen Wilms tumor 1 antigen (WT1). The newly described K b -restricted pWT330 epitope stimulates high-avidity allo-major histocompatibility c
Publikováno v:
International Immunology. 16:327-334
MDM2 is a tumour-associated antigen widely expressed by normal tissues and over-expressed by many tumours of different origin. We wanted to define the level of immunological tolerance against MDM2 and explore its potential in tumour immunotherapy. Tw
Autor:
Liquan Gao, Roopinder Gillmore, Daniel P. Hart, A Tsallios, A.‐M. Downs, Shao-An Xue, Hans J. Stauss, A. Tranter, G Bendle, Yasmeen Ghani, A. Holler, Francisco Ramirez, Emma C. Morris, S. Alcock
Publikováno v:
Blood Cells, Molecules, and Diseases. 33:288-290
Since malignant cells are derived from normal cells, many tumour-associated antigens are also expressed in normal tissues. For examples, WT1 is expressed at elevated levels in most leukaemias, but it is also expressed at reduced levels in normal CD34
Publikováno v:
PLoS Pathogens
PLoS Pathogens, Vol 9, Iss 1, p e1003145 (2013)
PLoS Pathogens, Vol 9, Iss 1, p e1003145 (2013)
Reverse genetics in the mosquito Anopheles gambiae by RNAi mediated gene silencing has led in recent years to an advanced understanding of the mosquito immune response against infections with bacteria and malaria parasites. We developed RNAi screens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ea3af7c0e454e7244a35fcf43346f70
http://hdl.handle.net/10044/1/91809
http://hdl.handle.net/10044/1/91809
Autor:
Hans J. Stauss, Suzanne Parry, Dimitri Hadjiminas, Shao-An Xue, R. Charles Coombes, Roberto Dina, Jonathan Waxman, Jaspal Kaeda, Ilaria Bellantuono, Yasmeen Ghani, Vourneen Healy, Angelika Holler, Roopinder Gillmore
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 12(1)
Purpose: The Wilms' tumor antigen (WT1) is overexpressed in ∼90% of breast tumors and, thus, is a potential target antigen for the immunotherapy of breast cancer. We have tested the working hypotheses that WT1 can be immunogenic in patients with br